Approval · Notice of Compliance 37229 · 2026
XBRYK: Notice of Compliance 37229
Issued March 30, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37229
- Date
- March 30, 2026
- Company
- Samsung Bioepis Co., LtdIncheon, Incheon, Korea, Republic Of
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Canadian reference product
- XGEVA
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| XBRYK | 02566923 | Approved |
Medicinal ingredients
- DENOSUMAB 120 MG per 1.7ML